GlassScriptPhysician profile
Amanda Hicks
NPI 1659887388
$3,744.36
in general payments reported to CMS, 2019-2025
36 companies · $698 in 2025
The $698 reported for 2025 was more than what 82% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $869 · 2023: $916 · 2024: $824 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,330 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,329.50 |
| Education | $108.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $351.72 | 2022-2025 | |
| Amgen INC. | $320.27 | 2021-2025 | Tavneos, Parsabiv, Uplizna |
| Ani Pharmaceuticals, INC. | $314.52 | 2023-2025 | Purified Cortrophin Gel |
| Fresenius USA Marketing, INC. | $296.07 | 2021-2024 | Velphoro |
| Astrazeneca Pharmaceuticals LP | $255.16 | 2021-2024 | Farxiga, Lokelma |
| Daiichi Sankyo INC. | $203.27 | 2021-2025 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $202.05 | 2021-2025 | Jynarque |
| Novo Nordisk INC | $160.14 | 2021-2025 | Ozempic |
| Mallinckrodt Hospital Products INC. | $122.12 | 2021-2025 | Acthar, Terlivaz |
| Novartis Pharmaceuticals Corporation | $121.35 | 2024-2025 | |
| Opko Pharmaceuticals, LLC | $117.79 | 2021-2023 | Rayaldee |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.77 | 2025 | Jardiance |
| Ardelyx, INC. | $101.14 | 2024-2025 | Ibsrela |
| Abbvie INC. | $98.57 | 2021-2023 | |
| Glaxosmithkline, LLC. | $92.82 | 2021-2025 | Benlysta, Shingrix |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $84.43 | 2022-2024 | |
| Vifor Pharma, INC. | $78.84 | 2021-2023 | Korsuva, Veltassa |
| Nestle Healthcare Nutrition INC. | $70.02 | 2022-2023 | |
| Akebia Therapeutics INC | $68.01 | 2021-2025 | Auryxia, Vafseo |
| Calliditas Therapeutics US INC. | $61.86 | 2023-2025 | Tarpeyo |
| Aurinia Pharma U.S., INC. | $59.92 | 2022-2023 | Lupkynis |
| Travere Therapeutics, INC. | $59.77 | 2023-2025 | Filspari |
| Kyowa Kirin, INC. | $48.63 | 2023-2025 | Crysvita |
| Alexion Pharmaceuticals, INC. | $40.57 | 2023-2024 | Ultomiris |
| Lexicon Pharmaceuticals, INC. | $39.90 | 2023 | Inpefa |
| Aimmune Therapeutics, INC. | $36.51 | 2024-2025 | Zenpep |
| Renalytix Ai, INC. | $34.71 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Alnylam Pharmaceuticals INC. | $33.69 | 2022 | |
| Nxstage Medical, INC. | $32.34 | 2022-2025 | Liberty Select Cycler |
| Leadiant Biosciences, INC. | $28.00 | 2024 | Cystaran |
| Gilead Sciences, INC. | $25.72 | 2024 | |
| Abiomed | $20.53 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $18.17 | 2024 | Exparel |
| Baxter Healthcare | $13.93 | 2025 | |
| Amag Pharmaceuticals, INC. | $12.78 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.